Malabsorption syndrome and leukotriene inhibitor

J Trop Pediatr. 2011 Apr;57(2):135-7. doi: 10.1093/tropej/fmq052. Epub 2010 Jun 22.

Abstract

Previously described treatments used for eosinophilic diseases of the gastrointestinal tract have included dietary restrictions primarily of cow milk protein, anti-inflammatory therapy utilizing suplatast, budesonide and corticosteroids, cromolyn sodium, anti-histamines and oral inhalable steroids. We describe a 12-year-old girl with diarrhea and malabsorption, who was later diagnosed to have eosinophilic gastroenteritis, was unresponsive to standard therapies, but exhibited marked improvement with use of montelukast.

Publication types

  • Case Reports

MeSH terms

  • Acetates / therapeutic use*
  • Child
  • Cyclopropanes
  • Diagnosis, Differential
  • Diarrhea / diagnosis
  • Endoscopy, Gastrointestinal
  • Enteritis / complications
  • Enteritis / diagnosis
  • Enteritis / drug therapy
  • Eosinophilia / complications
  • Eosinophilia / diagnosis
  • Eosinophilia / drug therapy
  • Female
  • Gastritis / complications
  • Gastritis / diagnosis
  • Gastritis / drug therapy
  • Humans
  • Leukotriene Antagonists / therapeutic use*
  • Malabsorption Syndromes / diagnosis
  • Malabsorption Syndromes / etiology
  • Quinolines / therapeutic use*
  • Sulfides
  • Treatment Outcome

Substances

  • Acetates
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • montelukast

Supplementary concepts

  • Eosinophilic enteropathy